Mediphar Labs. has participated in “Beirut International Healthcare Industry Forum"

Read more »

Mediphar Labs. has launched in the Lebanese market, OMEPRAL 20 mg powder for oral suspension in sachets.

Read more »

Mediphar Labs. has launched in the Lebanese market, ROVASTIN 10 mg, the superstatin.
ROVASTIN is a lipid-lowering agent that is indicated in the treatment of hypercholesterolemia.

Read more »

We care about your questions and concerns. Please call the consumer healthcare service:
+961 4 540056 or by email: chs@medipharlabs.com